secwatch / observer
8-K filed March 24, 2023, 7:59 PM ET ticker IART CIK 0000917520
debt confidence high sentiment neutral materiality 0.50

INTEGRA LIFESCIENCES HOLDINGS CORP (IART): debt financing — Integra LifeSciences enters $2.075B credit agreement, extends maturity to 2028

INTEGRA LIFESCIENCES HOLDINGS CORP

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

INTEGRA LIFESCIENCES HOLDINGS CORP incurred credit facility of up to $2.075 billion with Bank of America, N.A., as Administrative Agent at term SOFR plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%) maturing March 24, 2028.

Instrument
credit facility
Principal
up to $2.075 billion
Counterparty
Bank of America, N.A., as Administrative Agent
Rate
term SOFR plus 0.10% plus the applicable rate (ranging from 1.00% to 1.75%)
Maturity
March 24, 2028
Event
incurrence
Exact text from the filing
On March 24, 2023, Integra LifeSciences Holdings Corporation (the “Company”) entered into an amended and restated credit agreement with a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., JPMorgan Chase Bank, N.A., Morgan Stanley MUFG Loan Partners, LLC, PNC Bank, N.A., Truist Securities, Inc. and Wells Fargo Bank, N.A., as Co-Syndication Agents, and The Bank of Nova Scotia, BMO Harris Bank N.A., BNP Paribas, Capital One, National Association, Citizens Bank, N.A., DNB Bank ASA, New York Branch, Santander Bank, N.A. and TD Bank, N.A., as Co-Documentation Agents (the “Amendment and Restatement”). The Amendment and Restatement makes an aggregate principal amount of up to $2.075 billion available to the Company through the following facilities: (i) a $1.3 billion revolving credit facility, and (ii) a $775 million term loan facility, which includes a $60 million sublimit for the issuance of standby letters of credit
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INTEGRA LIFESCIENCES HOLDINGS CORP amended Amendment and Restatement with Bank of America, N.A., as Administrative Agent, and a syndicate of lending banks valued at $2.075 billion (effective 2023-03-24).

Action
amendment
Agreement
credit facility
Counterparty
Bank of America, N.A., as Administrative Agent, and a syndicate of lending banks
Value
$2.075 billion
Effective
2023-03-24
Exact text from the filing
On March 24, 2023, Integra LifeSciences Holdings Corporation (the “Company”) entered into an amended and restated credit agreement with a syndicate of lending banks, Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, Citibank N.A., JPMorgan Chase Bank, N.A., Morgan Stanley MUFG Loan Partners, LLC, PNC Bank, N.A., Truist Securities, Inc. and Wells Fargo Bank, N.A., as Co-Syndication Agents, and The Bank of Nova Scotia, BMO Harris Bank N.A., BNP Paribas, Capital One, National Association, Citizens Bank, N.A., DNB Bank ASA, New York Branch, Santander Bank, N.A. and TD Bank, N.A., as Co-Documentation Agents (the “Amendment and Restatement”).
View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR
accession 0000917520-23-000017
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.